XML 64 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation Expense (Details) - Schedule of Stock Options Vested and Exercisable - USD ($)
 3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Schedule of Stock Options Vested and Exercisable [Abstract]    
Shares, granted   245,500
Weighted- average exercise price, granted   $ 0.2
Shares, exercised  
Weighted-average exercise price, exercised  
Shares, cancelled/forfeited   (631,354)
Weighted-average exercise price, cancelled/forfeited   $ 1.32
Shares, outstanding at Ending balance 17,503,253 17,117,399
Weighted-average exercise price, outstanding at Ending balance $ 1.04 $ 1.02
Weighted-average remaining contractual term (years), outstanding at Ending balance 7 years 4 months 13 days 7 years 1 month 9 days
Aggregate intrinsic value, outstanding at Ending balance $ 42,527 $ 104,727
Shares, vested and expected to vest at ending balance   17,117,399
Weighted-average exercise price, vested and expected to vest at ending balance   $ 1.02
Weighted-average remaining contractual term (years), vested and expected to vest at ending balance   7 years 1 month 9 days
Aggregate intrinsic value, vested and expected to vest at ending balance   $ 104,727
Shares, vested and exercisable at ending balance   9,205,674
Weighted-average exercise price, vested and exercisable at ending balance   $ 0.96
Weighted-average remaining contractual term (years), vested and exercisable at ending balance   5 years 8 months 4 days
Aggregate intrinsic value, vested and exercisable at ending balance   $ 104,727